Phyllis R Yale insider trades

Open-market stock purchases and sales by Phyllis R Yale, Director at Bristol Myers Squibb Co, from SEC Form 4 filings since Jan 4, 2010.

Recent trades

DateStockTradeValue
Sep 30, 2026BMY Bristol Myers Squibb CoBought (not open market)$35K
Aug 15, 2026DVA Davita IncBought (not open market)—
Jun 30, 2026BMY Bristol Myers Squibb CoBought (not open market)$35K
May 26, 2026DVA Davita IncSold (not open market)—
May 15, 2026DVA Davita IncBought (not open market)—
Mar 31, 2026BMY Bristol Myers Squibb CoBought (not open market)$35K
Mar 15, 2026DVA Davita IncBought (not open market)—
Feb 1, 2026BMY Bristol Myers Squibb CoBought (not open market)$220K
Dec 31, 2025BMY Bristol Myers Squibb CoBought (not open market)—
Nov 15, 2025DVA Davita IncBought (not open market)—

Companies traded

  • BMY Bristol Myers Squibb Co: other filings, last Sep 30, 2026
  • DVA Davita Inc: 2 sales, last Aug 15, 2026
  • KND Kindred HealthCare, Inc: 1 buy, last Jul 2, 2018

Get free alerts when Phyllis R Yale files a new trade →